The use of estrogen receptor alpha modulators for the treatment of multiphe sclerosis

Details for Australian Patent Application No. 2004204675 (hide)

Owner Wyeth

Inventors Elloso, M. Merle; Mitchell, Robert; Harnish, Douglas C.; Adelman, Steven J.

Agent Peter Maxwell & Associates

Pub. Number AU-A-2004204675

PCT Pub. Number WO2004/062653

Priority 60/438,123 06.01.03 US

Filing date 5 January 2004

Wipo publication date 29 July 2004

International Classifications

A61K 031/00

A61P 037/00 Drugs for immunological or allergic disorders

A61P 037/06 Drugs for immunological or allergic disorders

A61K 031/4535

A61K 031/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

21 July 2005 PCT application entered the National Phase

  PCT publication WO2004/062653 Priority application(s): WO2004/062653

9 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004204683-Food and feed compositions including resistant starch

2004204674-System and method for stimulation of a person's brain stem